| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |